Retatrutide has progressed through Phase 2 clinical trials and into the Phase 3 TRIUMPH programme one of the most significant and closely watched clinical development programmes in metabolic research
Frohnert BI, Sinaiko AR, Serrot FJ, Foncea RE, Moran A, Ikramuddin S, et al
Look out for these red flags: Fatigue: Constant tiredness could mean your B12 or iron levels are tanking Hair Loss: A lack of biotin or other nutrients may leave your locks looking lackluster Brain Fog: Difficulty focusing could stem from low folate or B12 levels Bone Pain or Weakness: Could be linked to a lack of calcium or vitamin D Digestive Issues: Iron deficiency can cause constipation, while low vitamin D might lead to gut inflammation Pale Skin or Brittle Nails: Often a sign of low iron levels If you're noticing any of these symptoms, it's worth discussing with your healthcare provider
Adverse events in relation to GLP-1R agonists for the treatment of obesity are mainly gastrointestinal side effects, including nausea, diarrhoea, vomiting and constipation, which is consistent with observations in type 2 diabetes, and rates of discontinuation due to adverse events are generally higher with GLP-1R agonists treatment compared with placebo [26, 30,31,32,33,34,35,36,37,38,39]
Why choose Retatrutide